News
1484
Portfolio
60
Location:Sweden, Stockholm
News 1484
| Date | Title | Description |
| 09.04.2021 | Strongbrid... | RECORLEV® (levoketoconazole) ... |
| 09.04.2021 | Aprea Ther... | BOSTON, April 08, 2021 (GLOBE ... |
| 02.04.2021 | Fusion Pha... | - |
| 01.04.2021 | Change in ... | Lund, Sweden, 12:00 pm CET, 31... |
| 01.04.2021 | Increase o... | As previously announced, the C... |
| 01.04.2021 | Number of ... | |
| 28.03.2021 | Nordic Nan... | Source: Nordic Nanovector |
| 24.03.2021 | Spruce Bio... | Late-Stage CAHmelia Program in... |
| 24.03.2021 | Orexo publ... | - |
| 23.03.2021 | Oncopeptid... | |
| 23.03.2021 | Nordic Nan... | - |
| 23.03.2021 | Nordic Nan... | - |
| 22.03.2021 | Strongbrid... | ~ As Previously Reported, LOGI... |
| 19.03.2021 | Nordic Nan... | - |
| 18.03.2021 | Spruce Bio... | Tildacerfont Led to Significan... |
| 18.03.2021 | Targovax A... | Dr Quaratino is an R&D executi... |
| 18.03.2021 | Orexo cont... | Uppsala, Sweden – March 17, ... |
| 17.03.2021 | Aprea Ther... | BOSTON, March 16, 2021 (GLOBE ... |
| 17.03.2021 | Orexo publ... | Uppsala, Sweden – March 16 2... |
| 16.03.2021 | Oncopeptid... | - |
| 12.03.2021 | Vicore Pha... | The trial (NCT04388176) assess... |
| 11.03.2021 | Oncopeptid... | - |
| 10.03.2021 | Targovax g... | Extends patent protection of O... |
| 06.03.2021 | Press rele... | 2021-03-05;Approval of the boa... |
| 04.03.2021 | Strongbrid... | - |
| 04.03.2021 | Pulmonx Re... | - |
| 03.03.2021 | Fusion Pha... | - |
| 03.03.2021 | Strongbrid... | RECORLEV® (levoketoconazole) ... |
| 03.03.2021 | Spruce Bio... | SAN FRANCISCO–(BUSINESS WIRE... |
| 02.03.2021 | CARISMA Th... | PHILADELPHIA, March 1, 2021 /P... |
| 02.03.2021 | Nordic Nan... | - |
| 27.02.2021 | Year-end r... | 1 There is no dilution effect ... |
| 26.02.2021 | Strongbrid... | - |
| 24.02.2021 | Nordic Nan... | - |
| 24.02.2021 | Continued ... | Oslo, Norway, 23 February 2021... |
| 19.02.2021 | Oncopeptid... | - |
| 17.02.2021 | Strongbrid... | - |
| 17.02.2021 | Doctrin La... | 15 02 2021;The majority of Doc... |
| 17.02.2021 | Nordic Nan... | Oslo, Norway, 15 February 2020... |
| 16.02.2021 | Targovax r... | Oslo, Norway 15 February 2021 ... |
| 12.02.2021 | BONESUPPOR... | Lund, Sweden, 10.00 am CET, 10... |
| 12.02.2021 | Agenda for... | Oslo, 11 February 2021 – Tar... |
| 11.02.2021 | Vicore Pha... | ;Gothenburg, February 10, 2021... |
| 11.02.2021 | Targovax a... | Oslo, Norway 10 February 2021 ... |
| 11.02.2021 | Orexo star... | - |
| 10.02.2021 | Vicore Pha... | ;Gothenburg, February 9, 2021 ... |
| 10.02.2021 | SOTIO has ... | The phase I trial prostate can... |
| 02.02.2021 | Orexo expe... | - |
| 02.02.2021 | Positive d... | With close to 100 million regi... |
| 29.01.2021 | Orexo Q4 2... | - |
| 28.01.2021 | Orexo stre... | - |
| 21.01.2021 | InCarda Th... | Ongoing Trial to Evaluate Opti... |
| 14.01.2021 | GenSight B... | - |
| 08.01.2021 | Strongbrid... | Expects to Report KEVEYIS® (d... |
| 08.01.2021 | Spruce Bio... | -CAHmelia Adult Classic CAH Pr... |
| 08.01.2021 | CARISMA Th... | PHILADELPHIA, Jan. 7, 2021 /PR... |
| 08.01.2021 | Targovax g... | |
| 06.01.2021 | Aro Biothe... | – Aro’s proprietary Centyr... |
| 01.01.2021 | Orexo anno... | Uppsala, Sweden – December 3... |
| 29.12.2020 | Aprea Ther... | BOSTON, Dec. 28, 2020 (GLOBE N... |
| 22.12.2020 | Oncopeptid... | “Following the encouraging r... |
| 22.12.2020 | Positive r... | ;With COVID-19 increasing worl... |
| 19.12.2020 | Spruce Bio... | SAN FRANCISCO–(BUSINESS WIRE... |
| 18.12.2020 | BONESUPPOR... | Lund, Sweden, 11.00 CET, Dec 1... |
| 16.12.2020 | Vicore Pha... | “After reassuring that the s... |
| 11.12.2020 | GenSight B... | - |
| 11.12.2020 | Fusion Pha... | - |
| 11.12.2020 | Full data ... | The phase 2 HORIZON data are t... |
| 09.12.2020 | Vicore Pha... | 2020-12-08;;The ATTRACT study ... |
| 08.12.2020 | Oncopeptid... | At ASH Oncopeptides has presen... |
| 08.12.2020 | Oncopeptid... | The primary objective of the p... |
| 08.12.2020 | Orexo Ente... | Uppsala, Sweden – December 7... |
| 03.12.2020 | Targovax a... | Oslo, Norway, 1 December 2020 ... |
| 03.12.2020 | Targovax A... | With reference to the press re... |
| 02.12.2020 | Nordic Nan... | - |
| 01.12.2020 | Aprea Ther... | BOSTON, Nov. 30, 2020 (GLOBE N... |
| 01.12.2020 | Over 20,00... | he Zephyr Valve Helps COPD/Emp... |
| 01.12.2020 | Nordic Nan... | - |
| 01.12.2020 | Strong CER... | Lund, Sweden, 15.00 CET, Nov 3... |
| 25.11.2020 | Targovax d... | Oslo, Norway, 24 November 2020... |
| 25.11.2020 | Strongbrid... | - |
| 20.11.2020 | INTERIM RE... | ;The Interim Report Q3 2020 an... |
| 20.11.2020 | SPRUCE BIO... | –Successful Initiation of La... |
| 20.11.2020 | Nordic Nan... | - |
| 20.11.2020 | SynOx Ther... | Dublin, Ireland, November 19, ... |
| 20.11.2020 | Nordic Nan... | Source: Nordic Nanovector |
| 19.11.2020 | Vivet Ther... | PARIS, France and NEW YORK, N.... |
| 17.11.2020 | InCarda Th... | Data Demonstrate Achievement o... |
| 17.11.2020 | Vicore Pha... | Dr. Himanshu Pop Hale, Ace Hos... |
| 12.11.2020 | Pulmonx Re... | REDWOOD CITY, Calif., Nov. 10,... |
| 11.11.2020 | Fusion Pha... | - |
| 10.11.2020 | Targovax a... | The abstract presents the 12-m... |
| 07.11.2020 | Healthtech... | 29 10 2020;Health tech company... |
| 07.11.2020 | Aprea Ther... | BOSTON, Nov. 05, 2020 (GLOBE N... |
| 07.11.2020 | Interim re... | 1 There is no dilution effect ... |
| 06.11.2020 | BONESUPPOR... | - |
| 06.11.2020 | Targovax A... | Øystein Soug, CEO commented:;... |
| 05.11.2020 | Orexo Inte... | - |
| 05.11.2020 | Oncopeptid... | The updated analysis of the on... |
| 05.11.2020 | Correction... | - |
| 04.11.2020 | Vicore ann... | The management team in Vicore ... |
| 04.11.2020 | GenSight B... | Paris, France, Tuesday, Novemb... |
| 03.11.2020 | Pulmonx An... | REDWOOD CITY, Calif., Nov. 02,... |
| 03.11.2020 | Fusion Pha... | - |
| 03.11.2020 | Vicore str... | Vicore, which is developing fi... |
| 03.11.2020 | Fusion Pha... | - |
| 31.10.2020 | Strongbrid... | ~ Company on Track to Submit N... |
| 31.10.2020 | Healthtech... | Health tech company Doctrin ex... |
| 29.10.2020 | Targovax a... | Victor Levitsky, Chief Scienti... |
| 29.10.2020 | BONESUPPOR... | Lund, Sweden, 10.00 am CET, 28... |
| 26.10.2020 | InCarda Th... | Proceeds to Support Ongoing Cl... |
| 26.10.2020 | GenSight B... | Paris, France, October 22 2020... |
| - | Altimmune ... | Single dose of vaccine showed ... |
| - | Nexstim Pl... | Company announcement, Helsinki... |
| - | Nordic Nan... | - |
| - | Altimmune ... | GAITHERSBURG, Md., Oct. 08, 20... |
| - | WTX101 gra... | Dec 14, 2017;Wilson Therapeuti... |
| - | Strongbrid... | ~ Financing Comprised of $50 M... |
| - | Cerenis Th... | - |
| - | Strongbrid... | Strongbridge Commercial Introd... |
| - | New clinic... | Solna (Sweden) – July 2, 201... |
| - | BioClin Th... | SAN LEANDRO, Calif., October 2... |
| - | Single sta... | Lund, Sweden, 1 September 2016... |
| - | Onxeo to P... | During the presentation, Onxeo... |
| - | BONESUPPOR... | Rigshospitalet to evaluate CER... |
| - | Cash posit... | Toulouse, FRANCE, Ann Arbor, U... |
| - | INDUSTRIFO... | Glionova news release Industri... |
| - | New Englan... | - |
| - | Aprea Ther... | BOSTON, Oct. 02, 2019 (GLOBE N... |
| - | Strongbrid... | DUBLIN, Ireland and TREVOSE, P... |
| - | Nordic Nan... | Source: Nordic Nanovector |
| - | GenSight B... | Paris, France, Monday, July 6,... |
| - | Ultragenyx... | Agreement Reached With Both FD... |
| - | Nordic Nan... | Oslo, Norway and Solna, Sweden... |
| - | GenSight B... | - |
| - | HealthCap ... | Funds to be used to continue t... |
| - | BONESUPPOR... | - |
| - | GenSight B... | Paris, France, March 13, 2017 ... |
| - | Targovax A... | - |
| - | Orexo comm... | Uppsala, Sweden – June 27, 2... |
| - | Oncopeptid... | The company’s CEO Jakob Lind... |
| - | Strongbrid... | - |
| - | Bonesuppor... | Lund, Sweden, 12.00 CEST, 19 S... |
| - | Strongbrid... | ~ Launched KEVEYIS® (dichlorp... |
| - | Accelerate... | To NASDAQ OMX Copenhagen A/SAn... |
| - | Vicore Pha... | The Annual Report is available... |
| - | Nordic Nan... | - |
| - | Vicore Pha... | Only four weeks after submitti... |
| - | BONESUPPOR... | - |
| - | Targovax a... | Oslo, Norway, 21 January 2020 ... |
| - | National I... | ;;;REDWOOD CITY, California, D... |
| - | Wilson The... | In accordance with the decisio... |
| - | Nordic Nan... | - |
| - | Aprea Ther... | BOSTON, Sept. 18, 2020 (GLOBE ... |
| - | First pati... | - |
| - | Spruce Bio... | - |
| - | BONESUPPOR... | Lund, Sweden, 16.30 CET, 15 Ju... |
| - | Targovax r... | Oslo, Norway, 4 May 2020 – T... |
| - | VAXIN NAME... | Gaithersburg, Md., April 13, 2... |
| - | HealthTech... | Source: Doctrin;; |
| - | Modus Ther... | STOCKHOLM, SWEDEN – 07 Janua... |
| - | WILSON THE... | Wilson Therapeutics AB, announ... |
| - | Targovax g... | - |
| - | Bulletin f... | For further information, pleas... |
| - | Strongbrid... | - |
| - | Nexstim Pl... | Nexstim Plc (NXTMH:HEX, NXTMS:... |
| - | Targovax a... | Oslo, Norway, 24 June 2020 –... |
| - | Modus Ther... | STOCKHOLM, SWEDEN – 11 March... |
| - | BioClin Th... | SAN LEANDRO, Calif., September... |
| - | GLIONOVA R... | |
| - | Doctrin ap... | The Board of Directors has app... |
| - | NephroGene... | - |
| - | Targovax a... | Oslo, Norway, 7 February 2018 ... |
| - | Onxeo Anno... | Pharmaceutical and biotech ind... |
| - | MIPS: INTE... | APRIL – JUNE;JANUARY – JUN... |
| - | Carl-Johan... | The board of directors of Vico... |
| - | Nordic Nan... | Source: Nordic Nanovector |
| - | Rights iss... | Mölndal, October 9, 2018 – ... |
| - | Nexstim Pr... | Study on track and sites selec... |
| - | Nordic Nan... | - |
| - | Nordic Nan... | - |
| - | Strongbrid... | - |
| - | GenSight B... | - |
| - | Orexo broa... | Orexo broadens ZUBSOLV® produ... |
| - | Efficacy R... | Stockholm, Sweden Oncopeptide... |
| - | Informatio... | ReLive is an international, ra... |
| - | Onxeo rece... | - |
| - | Wilson The... | Significant events during the ... |
| - | Ultragenyx... | - |
| - | Strongbrid... | - |
| - | GenSight B... | - |
| - | Positive r... | - |
| - | Oncopeptid... | Due to the COVID-19 pandemic, ... |
| - | MIPS – Y... | THU, FEB 14, 2019 07:30 CET;OC... |
| - | Rainier Th... | – Preliminary data from FIER... |
| - | Oncopeptid... | Stockholm, Sweden;Oncopeptides... |
| - | Nordic Nan... | - |
| - | Strongbrid... | ~ Data Suggest Levoketoconazol... |
| - | Vivet Ther... | PARIS, France and NEW YORK, N.... |
| - | First pati... | • CER-001 is a novel HDL-mim... |
| - | Targovax s... | For further information, pleas... |
| - | Nordic Nan... | - |
| - | Orexo anno... | Uppsala, Sweden – May 20, 20... |
| - | Aprea Ther... | - |
| - | Phase 2 Cl... | Oct 06, 2017;Wilson Therapeuti... |
| - | Nordic Nan... | - |
| - | Intravitre... | Paris, France, February 12, 20... |
| - | Nordic Nan... | Source: Nordic Nanovector |
| - | Strongbrid... | DUBLIN, Ireland and TREVOSE, P... |
| - | Orexo and ... | UPPSALA, SWEDEN, AND NEW YORK,... |
| - | Digital Th... | September 22, 2020;Trinity Hea... |
| - | Change in ... | 12 October 2017;Nexstim Plc (N... |
| - | Cortendo P... | Cortendo Expands Board of Dire... |
| - | Oncopeptid... | Melflufen is a first-in-class ... |
| - | BONESUPPOR... | - |
| - | Foundation... | We are proud to share the news... |
| - | Cerenis Th... | • CER-001 mimics native HDL ... |
| - | Nordic Nan... | - |
| - | Lancet Pub... | REDWOOD CITY, Calif.–(BUSINE... |
| - | Cortendo A... | July 20, 2015 – Göteborg, S... |
| - | Altimmune ... | GAITHERSBURG, Md., Dec. 06, 20... |
| - | Nordic Nan... | - |
| - | Targovax A... | - |
| - | MIPS + BRG... | The Swedish research and devel... |
| - | Nordic Nan... | - |
| - | Oncopeptid... | The annual report is available... |
| - | Onxeo: Q1 ... | Paris, April 26, 2017 – 6.30... |
| - | Updated re... | Oslo, Norway, 28 April 2017;No... |
| - | Targovax e... | Oslo, Norway 4 June 2020 – T... |
| - | Orexo’s ... | Morristown, NJ – June 25, 20... |
| - | Targovax i... | First patient enrolled in a Ph... |
| - | Nordic Nan... | - |
| - | Nordic Nan... | The Board of Nordic Nanovector... |
| - | Wilson The... | Apr 27, 2018;As of today, the ... |
| - | Nordic Nan... | - |
| - | Targovax a... | - |
| - | MIPS INTER... | 7:30 am / August 16, 2018;APR ... |
| - | NORDIC NAN... | Oslo, Norway, 11 April 2016;No... |
| - | Oncopeptid... | Stockholm, Sweden Oncopeptide... |
| - | Patient re... | Oncopeptides is engaged in pre... |
| - | Onxeo succ... | Offering upsized in response t... |
| - | Strongbrid... | ~ Phase 3 LOGICS Study of RECO... |
| - | MIPS annou... | ON, MAR 13, 2017 07:30 CET;MIP... |
| - | Targovax a... | Oslo, Norway, 8 January 2018: ... |
| - | ;Nordic Nanovector AS announce... | |
| - | Strongbrid... | ~ KEVEYIS®(dichlorphenamide) ... |
| - | NANO: LATE... | Oslo, Norway, 1 March 2016;Nor... |
| - | Targovax r... | - |
| - | Targovax a... | Oslo, Norway, 3 March 2020 –... |
| - | Orexo sign... | - |
| - | MIPS AB re... | MIPS AB (”MIPS”) has recei... |
| - | Altimmune ... | New funding will allow examina... |
| - | Nordic Nan... | Data presented at the ASH Annu... |
| - | Strongbrid... | DUBLIN, Ireland and TREVOSE, P... |
| - | Fusion Pha... | BOSTON, MA and HAMILTON, ONTAR... |
| - | BioClin Th... | SAN RAMON, Calif., Aug. 10, 20... |
| - | Targovax a... | Source: Targovax;; |
| - | Targovax a... | Oslo, Norway, 23 June 2020 –... |
| - | Completion... | Oslo, 9 July 2015: Targovax AS... |
| - | Tisbury Ph... | Boston, Massachusetts (PRWEB) ... |
| - | Altimmune ... | Patent Will Specifically Cover... |
| - | Nordic Nan... | - |
| - | GenSight B... | Paris, France, November 6, 201... |
| - | GenSight B... | GenSight Biologics S.A. (GenSi... |
| - | Altimmune ... | GAITHERSBURG, Md., Sept. 09, 2... |
| - | Targovax A... | |
| - | Cash posit... | Toulouse, FRANCE, Ann Arbor, U... |
| - | Targovax a... | - |
| - | Vicore Pha... |